These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 38211527)

  • 1. Impact of tumor subsite on survival outcomes in oral squamous cell carcinoma: A retrospective cohort study from 2000 to 2019.
    Justesen MM; Stampe H; Jakobsen KK; Andersen AO; Jensen JM; Nielsen KJ; Gothelf AB; Wessel I; Christensen A; Grønhøj C; von Buchwald C
    Oral Oncol; 2024 Feb; 149():106684. PubMed ID: 38211527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Tumor Size, Subsite, and Adjuvant Therapy on Outcomes in pT4aN0 Oral Cavity Carcinoma.
    Namin AW; Bollig CA; Harding BC; Dooley LM
    Otolaryngol Head Neck Surg; 2020 May; 162(5):683-692. PubMed ID: 32069171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does anatomic subsite influence oral cavity cancer mortality? A SEER database analysis.
    Farhood Z; Simpson M; Ward GM; Walker RJ; Osazuwa-Peters N
    Laryngoscope; 2019 Jun; 129(6):1400-1406. PubMed ID: 30408182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relative propensity for regional metastasis in floor of mouth squamous cell carcinoma versus other oral cavity subsites.
    Wicks C; Zubair F; Ogunbowale A; McMahon J
    Br J Oral Maxillofac Surg; 2022 Nov; 60(9):1276-1278. PubMed ID: 36229310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodal Metastasis in Surgically Treated Oral Cavity Squamous Cell Carcinoma.
    Carey RM; Anagnos VJ; Prasad A; Sangal NR; Rajasekaran K; Shanti RM; Cannady SB; Newman JG; Brant JA; Brody RM
    ORL J Otorhinolaryngol Relat Spec; 2023; 85(6):348-359. PubMed ID: 37967536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.
    Jerjes W; Upile T; Petrie A; Riskalla A; Hamdoon Z; Vourvachis M; Karavidas K; Jay A; Sandison A; Thomas GJ; Kalavrezos N; Hopper C
    Head Neck Oncol; 2010 Apr; 2():9. PubMed ID: 20406474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact on patients with oral squamous cell carcinoma in different anatomical subsites: a single-center study in Taiwan.
    Lin NC; Hsien SI; Hsu JT; Chen MYC
    Sci Rep; 2021 Jul; 11(1):15446. PubMed ID: 34326432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of dysplasia and primary site associated with recurrence in T1N0 oral squamous cell carcinoma.
    Liu Y; Shah N; Summersgill K; Kumar S
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jul; 132(1):66-71. PubMed ID: 34020919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival.
    Brandwein-Gensler M; Teixeira MS; Lewis CM; Lee B; Rolnitzky L; Hille JJ; Genden E; Urken ML; Wang BY
    Am J Surg Pathol; 2005 Feb; 29(2):167-78. PubMed ID: 15644773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing Epidemiology of Oral Cavity Cancer in the United States.
    Stepan KO; Mazul AL; Larson J; Shah P; Jackson RS; Pipkorn P; Kang SY; Puram SV
    Otolaryngol Head Neck Surg; 2023 Apr; 168(4):761-768. PubMed ID: 35503657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour thickness as a predictor of nodal metastases in oral cancer: comparison between tongue and floor of mouth subsites.
    Balasubramanian D; Ebrahimi A; Gupta R; Gao K; Elliott M; Palme CE; Clark JR
    Oral Oncol; 2014 Dec; 50(12):1165-8. PubMed ID: 25307875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Success of salvage treatment: a critical appraisal of salvage rates for different subsites of HNSCC.
    Matoscevic K; Graf N; Pezier TF; Huber GF
    Otolaryngol Head Neck Surg; 2014 Sep; 151(3):454-61. PubMed ID: 24894422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elective Neck Dissection in T1N0M0 Oral Squamous Cell Carcinoma: When Is It Necessary?
    Feng Z; Cheng A; Alzahrani S; Li B; Han Z; Ward BB
    J Oral Maxillofac Surg; 2020 Dec; 78(12):2306-2315. PubMed ID: 32730759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Histologic Risk Factors on Recurrence Rates for Oral Cavity Squamous Cell Carcinoma.
    Kligerman MP; Moon PK; Tusty M; Cloutier JM; Ma Y; Holsinger CF; Divi V
    Ann Otol Rhinol Laryngol; 2023 Jul; 132(7):731-737. PubMed ID: 35899590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of Anteroposterior Extension in Oral Tongue and Floor Squamous Cell Carcinoma.
    Contro G; Sordi A; Taboni S; Citterio M; Ruaro A; De Lucia G; Pinacoli A; Carobbio ALC; Montalto N; Ramacciotti G; Grammatica A; Marioni G; Zanoletti E; Maroldi R; Piazza C; Mattavelli D; Nicolai P; Ferrari M
    JAMA Otolaryngol Head Neck Surg; 2024 Feb; 150(2):142-150. PubMed ID: 38153706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.
    Chow JCH; Cheuk W; Cho WCS; Wong CF; Au DWY; Tam AHP; Wong RCW; Chan JCH; Law SCC; Ngan RKC; Wong KH; Cheung KM
    JAMA Netw Open; 2023 Jul; 6(7):e2323890. PubMed ID: 37459093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating depth of invasion across oral cavity subsites as part of the AJCC 8th edition T staging criteria for oral cavity squamous cell carcinoma.
    Gilja S; Barlow J; Kumar A; Berger MH; Khan MN; Kirke DN; Roof SA
    Head Neck; 2023 Nov; 45(11):2780-2788. PubMed ID: 37698539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative intensity-modulated radiotherapy following surgery for oral cavity squamous cell carcinoma: patterns of failure.
    Chan AK; Huang SH; Le LW; Yu E; Dawson LA; Kim JJ; Cho BC; Bayley AJ; Ringash J; Goldstein D; Chan K; Waldron J; O'Sullivan B; Cummings B; Hope AJ
    Oral Oncol; 2013 Mar; 49(3):255-60. PubMed ID: 23079695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncologic Outcome in Advanced Oral Squamous Cell Carcinoma After Refusal of Recommended Adjuvant Therapy.
    Mrosk F; Doll C; Scheer J; Neumann F; Hofmann E; Kreutzer K; Voss J; Rubarth K; Beck M; Heiland M; Koerdt S
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):1027-1033. PubMed ID: 37824130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rates of Occult Invasive Disease in Patients With Biopsy-Proven Oral Cavity Squamous Cell Carcinoma in Situ.
    Cooper DJ; Ziemba Y; Pereira L; Kann BH; Parashar B; Miles BA; Ghaly M; Seetharamu N; Frank D; Talcott WJ
    JAMA Otolaryngol Head Neck Surg; 2024 Feb; 150(2):151-156. PubMed ID: 38175664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.